Industry News
Excerpt from the article: “We have recently reported that two drugs, remdesivir (GS-5734) and chloroquine (CQ) phosphate, efficiently inhibited SARS-CoV-2 infection in vitro1. Remdesivir is a nucleoside analog prodrug developed by Gilead Sciences (USA). A recent case report showed that treatment with remdesivir improved the clinical condition of the first patient infected by SARS-CoV-2 in…
Read More
The U.S. Food and Drug Administration today issued a guidance for industry, investigators and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic. Click the button below to read the entire Guidance from the FDA! Continue Reading The Guidance
Read More
The first human tests for a Coronavirus vaccine have taken place in Seattle, according to the National Institutes of Health. Click the button below to read the entire article! Continue To The Article
Read More
New research finds that the virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces. Scientists found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detectable in aerosols for up to three hours, up to four hours on copper, up to 24 hours on cardboard…
Read More
Melbourne researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection UNIVERSITY OF MELBOURNE Click the button below to read the entire article! Continue To The Article
Read More
The Hamilton Spectator building will soon become a hub for emerging life sciences companies. McMaster Innovation Park is the new owner of The Spectator building at 44 Frid St., the newspaper’s home since 1976. MIP plans to convert the building into a state-of-the-art hub complete with labs and office space for emerging life sciences companies.…
Read More
The 2020 Medicine by Design New Ideas Awards will focus on seeding new ideas that have strong potential to advance regenerative medicine research. Each funded project will receive up to $100,000 per year for a two-year period from July 1, 2020, to June 30, 2022. Proposed projects must align with at least one of the…
Read More
The ONtrepreneurs (Ontario Neurotech Entrepreneurs) Program is Canada’s single largest award that catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures. Application for the 2020 ONtrepreneurs Competition is NOW OPEN! Click the button below to read his entire Article! Continue To The Site To…
Read More
Bruno Villetelle, Head of Data and Digital, Novartis Global Drug Development, wrote a very succinct summary of the core topics covered at J.P. Morgan 2020. We’re excited to see the continued momentum behind these digital trends and how we’re enabling Sponsors to take advantage of Real World Data, Machine Learning and so much more through…
Read More
This may just be the first drug to be generated using artificial intelligence (AI) which has now entered clinical trials in Japan. “The project has been particularly heralded for the speed it took to complete – taking just 12 months when compared to the typical five years it takes drug companies to complete the research…
Read More